Since its founding in 2012, SDS Life Science has grown into a multi-disciplinary team of handpicked specialists with regulatory and scientific knowledge in medicinal product development and statistics. Our ambition is to guide our clients in transforming their research hypotheses into full clinical studies. We adopt a holistic approach in collaboration with our clients to provide the best solutions for each unique project. Our passion is to solve those tricky questions which have no obvious answers. Since 2022, the SDS group is part of Cytel Inc.
The SDS group has joined Cytel Inc.
Cytel Inc has agreed with the SDS Group to acquire SDS Life Science AB and SDS MedteQ AB
What is Real World Evidence - and why do we need it?
It is essential to conduct randomized controlled studies in drug development. However, these are not always sufficient to get approval from regulatory bodies.
Regulatory affairs considerations for drug development
Why is it so important for Life Science companies to invest in regulatory affairs activities as part of their drug development programs?
A One-Stop Shop for Drug Development
Welcome to SDS Life Science
Learn more about us
We'd like to think that our distinction lies within our multidisciplinarity. Drug development is complex and requires experts within several unique disciplines such as toxicology, pharmacology, biostatistics, real world evidence, regulatory affairs, and clinical project management. Read more about our services here.
Visit our sister company SDS MedteQ
SDS Life Science is one of two companies within the SDS Group. Our sister company SDS MedteQ offers expertise in medical device development, quality assurance, regulatory affairs, compliance project management, clinical development, IVD and combination products.
Who we serve